356.52

0.45% -1.89

West Pharmaceutical Services Inc (WST)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt WST? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$358.41

Offen:

$385

24-Stunden-Volumen:

1.37M

Relative Volume:

1.65

Marktkapitalisierung:

$25.16B

Einnahmen:

$3.22B

Nettoeinkommen (Verlust:

$542.70M

KGV:

47.66

EPS:

7.4805

Netto-Cashflow:

$458.00M

1W Leistung:

-1.56%

1M Leistung:

+6.07%

6M Leistung:

+50.76%

1J Leistung:

+56.97%

1-Tages-Spanne:

$351.18

$386.00

1-Wochen-Bereich:

$345.70

$386.00

52-Wochen-Spanne:

$223.83

$386.00

West Pharmaceutical Services Inc Stock (WST) Company Profile

Firmenname

West Pharmaceutical Services Inc

Sektor

Healthcare (1081)

Branche

Medical Instruments & Supplies (57)

Telefon

(610) 594-2900

Adresse

530 HERMAN O. WEST DRIVE, EXTON, PA

Mitarbeiter

10,800

Twitter

@WestPharma

Nächster Verdiensttermin

2026-07-23

Neueste SEC-Einreichungen

WST's Discussions on Twitter

Compare WST vs ISRG, BDX, ALC, MDLN, RMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
WST West Pharmaceutical Services Inc	356.12	25.32B	3.22B	542.70M	458.00M	7.4805
ISRG Intuitive Surgical Inc	331.32	122.06B	11.03B	3.16B	2.83B	8.7254
BDX Becton Dickinson Co	152.83	42.20B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	67.14	32.85B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	37.45	31.44B	29.14B	1.07B	1.05B	1.1956
RMD Resmed Inc	191.10	27.98B	5.54B	1.52B	1.74B	10.37

West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-02	Eingeleitet	Morgan Stanley	Equal-Weight
2025-09-15	Eingeleitet	Rothschild & Co Redburn	Buy
2025-06-24	Eingeleitet	Barclays	Equal Weight
2025-03-18	Eingeleitet	Evercore ISI	Outperform
2025-02-14	Hochstufung	Deutsche Bank	Hold → Buy
2025-01-08	Eingeleitet	Citigroup	Buy
2024-12-13	Eingeleitet	Wolfe Research	Peer Perform
2024-12-12	Hochstufung	UBS	Neutral → Buy
2024-02-07	Hochstufung	Jefferies	Hold → Buy
2023-06-16	Hochstufung	BofA Securities	Neutral → Buy
2023-04-11	Hochstufung	Stephens	Equal-Weight → Overweight
2022-12-14	Eingeleitet	Deutsche Bank	Hold
2022-11-30	Eingeleitet	UBS	Neutral
2022-10-28	Herabstufung	BofA Securities	Buy → Neutral
2020-11-10	Eingeleitet	KeyBanc Capital Markets	Overweight
2020-10-14	Eingeleitet	Stephens	Equal-Weight
2020-07-21	Hochstufung	BofA Securities	Neutral → Buy
2020-04-24	Hochstufung	BofA/Merrill	Underperform → Neutral
2019-12-12	Herabstufung	BofA/Merrill	Neutral → Underperform
2019-07-26	Hochstufung	BofA/Merrill	Underperform → Neutral
2019-05-01	Herabstufung	Jefferies	Buy → Hold
2019-04-23	Eingeleitet	William Blair	Outperform
2018-04-25	Herabstufung	BofA/Merrill	Neutral → Underperform
2018-01-24	Eingeleitet	Goldman	Neutral
2017-10-17	Herabstufung	BofA/Merrill	Buy → Neutral
2017-10-03	Eingeleitet	Stephens	Equal-Weight
2017-09-15	Hochstufung	Jefferies	Hold → Buy
2016-10-28	Hochstufung	Wells Fargo	Market Perform → Outperform
2016-09-21	Herabstufung	Wells Fargo	Outperform → Market Perform
2016-03-22	Eingeleitet	Wells Fargo	Outperform
2010-05-14	Bestätigt	UBS	Neutral
2010-02-23	Eingeleitet	Jefferies & Co	Buy
2008-12-19	Eingeleitet	UBS	Neutral

Alle ansehen

West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten

12:07 PM

West Pharmaceutical Services (WST) Reports Strong Q2 2026 Earnin - GuruFocus

12:07 PM

11:43 AM

Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 17, 2026. - marketscreener.com

11:43 AM

11:32 AM

West Pharmaceutical CEO Highlights GLP-1 And Biologics Momentum - Benzinga

11:32 AM

11:11 AM

West Pharma raises profit forecast on strong demand for injectable drug components - Reuters

11:11 AM

10:41 AM

West Pharmaceutical Services, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

10:41 AM

09:42 AM

Earnings call transcript: West Pharmaceutical beats Q2 2026 estimates, lifts outlook - Investing.com

09:42 AM

09:30 AM

West Pharmaceutical (WST) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

09:30 AM

09:22 AM

West Pharmaceutical Services (NYSE:WST) Beats Expectations in Strong Q2 CY2026, Stock Soars - Yahoo Finance

07:58 AM

07:16 AM

Form 8-K WEST PHARMACEUTICAL SERV For: Jul 23 - StreetInsider

07:16 AM

07:15 AM

West Pharmaceutical Services (WST) Q2 Earnings and Revenues Top Estimates - Yahoo Finance

07:15 AM

06:51 AM

West Pharma stock rises 6% on strong earnings beat and raised guidance - Investing.com UK

06:51 AM

West Pharmaceutical raises FY2026 sales and EPS guidance - scanx.trade

06:51 AM

06:37 AM

West Pharmaceutical raises annual profit forecast on strong demand for injectable drug components - marketscreener.com

06:37 AM

06:28 AM

(WST) West Pharmaceutical Services, Inc. Expects Q3 Revenue Range $820.0M$835.0M - marketscreener.com

06:28 AM

West Pharmaceutical Services earnings beat by $0.29, revenue topped estimates - Investing.com Canada

06:28 AM

06:27 AM

(WST) West Pharmaceutical Services Expects Full Year 2026 Adjusted EPS Range $8.85$9.05, vs. FactSet Est of $8.62 - marketscreener.com

06:27 AM

06:26 AM

Earnings Flash (WST) West Pharmaceutical Services, Inc. Reports Q2 Revenue $872.3M, vs. FactSet Est of $840.0M - marketscreener.com

06:26 AM

(WST) West Pharmaceutical Services Expects Full Year 2026 Net Sales Range $3.35B$3.38B vs. FactSet Est of $3.33B - marketscreener.com

06:26 AM

06:25 AM

Earnings Flash (WST) West Pharmaceutical Services, Inc. Posts Q2 Adjusted EPS $2.37 per Share, vs. FactSet Est of $2.08 - marketscreener.com

06:25 AM

06:19 AM